FIELD: medicine.
SUBSTANCE: invention relates to medicine and relates to a method for quantitatively assessing platelet aggregation activity in patients with new coronavirus infection, which consists in taking blood from a patient, obtaining platelet mass, preparing it and conducting a study of platelet aggregation by spectrometric method with an inductor of adenosine diphosphate at a concentration of 0.3 mcg/ml with the measurement of the values of the maximum degree, the rate and time of platelet aggregation, where the area under the optical density curve is additionally determined to the maximum degree of aggregation and at its value in the range of 9.8-20.4 c.u. the aggregation activity of platelets is assessed as normal, over 20.4 c.u. - as increased, and below 9.8 c.u. - as reduced.
EFFECT: invention provides a rapid quantitative assessment of platelet aggregation activity in patients with COVID-19 infection.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ESTIMATION OF AGGREGATION ACTIVITY OF THROMBOCYTES | 2016 |
|
RU2666945C2 |
| METHOD FOR THROMBOCYTE AGGREGATION ACTIVITY DETERMINATION FOR PATIENTS WITH ACUTE CORONARY SYNDROME | 2016 |
|
RU2619858C1 |
| METHOD FOR EVALUATING AGGREGATION PROPERTIES OF BLOOD PLATELETS | 2001 |
|
RU2213976C2 |
| METHOD OF INDIVIDUAL PROGNOSIS OF CLINICAL EFFECTIVENESS OF DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2016 |
|
RU2639772C1 |
| METHOD FOR ESTIMATING CLINICAL EFFECTIVENESS OF ANTIAGGREGANT THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2011 |
|
RU2486523C1 |
| METHOD OF INTEGRAL ASSESSMENT OF MORPHOFUNCTIONAL STATUS OF PLATELETS DURING EXPERIMENTAL ORTHOPAEDIC SURGICAL INTERVENTIONS | 2022 |
|
RU2814398C1 |
| METHOD FOR DIAGNOSING BLOOD PLATELETS STAGE DISORDER OF HEMOSTASIS IN INFECTIOUS PATHOLOGY CASES | 1999 |
|
RU2151402C1 |
| DIAGNOSTIC TECHNIQUE FOR DISTURBED THROMBOCYTE AGGREGATION ACCOMPANYING MUCOVISCIDOSIS IN CHILDREN | 2013 |
|
RU2533287C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH NEW CORONAVIRUS INFECTION (COVID-19) | 2020 |
|
RU2745774C1 |
| METHOD OF SECONDARY POST-TRAUMATIC INTRAOCULAR HEMORRHAGE FORECAST | 2007 |
|
RU2349251C1 |
